Product Overview

Improved lung nodule detection

Early detection of lung cancer is a key factor in improving patient outcomes. OnGuard chest X-ray CAD is the practical solution for identifying nodules that may be early-stage lung cancer*. The newest FDA approved version offers superior marking capabilities with a 73% reduction in false positives and 50% relative improvement in sensitivity.

Enhanced Workflow

Featuring universal PACS connectivity, OnGuard seamlessly integrates into any digital radiology department, functioning with all CR and DR devices. The powerful OnGuard algorithm automatically processes chest X-rays for your interpretation within the patient series. Viewing the OnGuard marker is as easy as the click of a mouse or keyboard button, all without the need for a separate workstation.

Key Advantages

• Maker scales to reflect the nodule size without obscuring the boundary
• Low false positive rate and improved sensitivity for optimal performance
• Improves the detection of 9-30 mm nodules**
• Can detect up to 50% of missed nodules***
• Automatic display of CAD markers on existing PACS reading workstations for enhanced workflow efficiency
• Universal PACS connectivity for a quick and seamless installation
• Uses existing chest X-ray – No additional hardware necessary

* http://lungcancer.about.com/od/typesoflungcancer/a/spn.htm
** Riverain Medical FDA PMA Clinical Trial
*** C. White, T. Flukinger, J. Jeudy and J. Chen (2009) Use of a Computer-Aided Detection System to Detect Missing Lung Cancer at Chest Radiography. Radiology. 252: 273-281